References
The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
7 – Morgan E. Levine et al., Cell Metabolism 19, no. 3, 407–17, March 2014
Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population
8 – Abeer M. Mahmoud and Mohamed M. Ali, Nutrients 11, no. 3, 608, March 2019
Methyl Donor Micronutrients That Modify DNA Methylation and Cancer Outcome
9 – Long N. Nguyen et al., Nature 509, 503–06, May 2014
Mfsd2a Is a Transporter for the Essential Omega-3 Fatty Acid Docosahexaenoic Acid
10 – R. Douglas Fields, Science 330, 768–69, November 2010
Change in the Brain’s White Matter
10 – Michael J. Weiser, Christopher M. Butt, and M. Hasan Mohajeri, Nutrients 8, no. 2, 99, February 2016
Docosahexaenoic Acid and Cognition Throughout the Lifespan
11 – Philip C. Calder, Annals of Nutrition and Metabolism 69, supplement 1, 8–21, November 2016
Docosahexaenoic Acid
12 – R. Peters, Postgraduate Medical Journal 82, no. 964, 84–88, February 2006
Ageing and the Brain
12 – Marzia Perluigi, Aaron M. Swomley, and D. Allen Butterfield, Ageing Research Reviews 13, no. 1, 75–89, December 2013
Redox Proteomics and the Dynamic Molecular Landscape of the Aging Brain
12 – Junji Egawa et al., Journal of Physiology 594, no. 16, 4565–79, August 2016
Membrane Lipid Rafts and Neurobiology: Age-Related Changes in Membrane Lipids and Loss of Neuronal Function
13 – Eric M. Ammann et al., Prostaglandins Leukotrienes and Essential Fatty Acids 121, 68–75, June 2017